Latest Breaking News On - Peter hovstadius - Page 1 : comparemela.com

HUDDINGE, Sweden, Jan. 19, 2023 /PRNewswire/ XNK Therapeutics AB ("XNK") today announced the appointment of Dr. Peter Hovstadius as Chief Medical Officer (CMO), effective immediately. Dr.

Uppsala lanKostenloser wertpapierhandelJohan liwingJohan aschanPeter hovstadiusUppsala universityClinical development of the novel cyanoguanidineChief medical officerSenior medicalClinical developmentNovel cyanoguanidineCancer treatmentMedical directorChief scientific officerChief innovation officerSenior medical advisor